Motilal Oswal Alternates invested $72M in Sensa Core, an Indian medical device company. Sensa Core will use the funds to boost product development and expand globally in the IVD segment. The investment aims to reduce India’s reliance on medical device imports and support indigenous manufacturing and exports.
Trending
- Fraganote Secures $3 Million Series A to Propel D2C Growth and Portfolio Expansion
- Fraganote Secures $3 Million Series A to Propel D2C Growth and Portfolio Expansion
- Amazon Prime Music in India to Introduce Ads, Remove Offline Downloads From July 2026
- Amazon Prime Music in India to Introduce Ads, Remove Offline Downloads From July 2026
- Acko Taps Top Banks for H1 2027 IPO Target
- Fairdeal.Market Secures US$15M to Scale B2B Quick Commerce Across India
- India’s Startup IPO Surge: 48+ Listings Set to Unlock INR 50,000 Cr in 2026
- Indian Startup IPO Surge Expected by 2026 Amid Market Reset


